Last update 07 Jun 2025

SYH2068

Overview

Basic Info

Drug Type
siRNA
Synonyms
SYH2068
Target
Lp(a)
Action
inhibitors
Mechanism
lipoprotein(a) inhibitors
Therapeutic Areas
Endocrinology and Metabolic Disease
Active Indication
Lipoprotein (a) hyperlipoproteinemia
Inactive Indication-
Originator Organization
CSPC ZhongNuo Pharmaceutical (Shijiazhuang) Co. Ltd.CSPC ZhongNuo Pharmaceutical (Shijiazhuang) Co. Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Active Organization
CSPC ZhongNuo Pharmaceutical (Shijiazhuang) Co. Ltd.CSPC ZhongNuo Pharmaceutical (Shijiazhuang) Co. Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Boost your research with our RNA technology data.
login
or
view full example data
Boost your research with our RNA technology data.

Related

1
Clinical Trials associated with SYH2068
CTR20252120
/ Not yet recruitingPhase 1
一项单中心、随机、双盲、安慰剂对照、单剂量递增、评价SYH2068注射液在中国脂蛋白（a）升高健康参与者中的安全性、耐受性、药代动力学和药效学特征的I期临床试验
[Translation] A single-center, randomized, double-blind, placebo-controlled, single-ascending dose clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SYH2068 injection in healthy Chinese participants with elevated lipoprotein (a)
100 Clinical Results associated with SYH2068
Login to view more data
100 Translational Medicine associated with SYH2068
Login to view more data
100 Patents (Medical) associated with SYH2068
Login to view more data
100 Deals associated with SYH2068
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lipoprotein (a) hyperlipoproteinemiaPhase 1
China
CSPC ZhongNuo Pharmaceutical (Shijiazhuang) Co. Ltd.CSPC ZhongNuo Pharmaceutical (Shijiazhuang) Co. Ltd.
05 Jun 2025
Lipoprotein (a) hyperlipoproteinemiaPhase 1
China
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
05 Jun 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free